Bazedoxifene acetate
CAS: 198481-33-3
Molecular Formula: C30H34N2O3.C2H4O2
Molecular Weight: 530.661
Product description:1713 a competitive inhibition of estradiol and the combination of estrogen receptor ERoc and ER13 has estrogen agonist activity to the bone, can improve the bone mineral density of the spine and hip, so can significantly reduce the postmenopausal osteoporosis vertebral fracture risk.
Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.
Promotion,New Products,And any other assistance.
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@aushealthingredients.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6516 2351
4. Send enquiry online: